2017
DOI: 10.1111/jgh.13776
|View full text |Cite
|
Sign up to set email alerts
|

Germline mutations in patients with multiple colorectal polyps in China

Abstract: A genetic screening strategy comprising 19 genes was effective to screen for hereditary CRC syndromes in patients with multiple colorectal polyps. The MUTYH germline mutation hotspots in Chinese patients may be different from those in Caucasian patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 46 publications
(98 reference statements)
0
11
0
Order By: Relevance
“…In keeping with this, we observed that MUTYH c.934-2A > G variant alleles in heterozygous carriers (L130, L279, L522, and L239) were selectively expressed over wild-type alleles, suggesting that most of the MUTYH protein expressed may be defective. Notably, however, although heterozygous c.934-2A > G has been reported in several individuals with colorectal adenomas and carcinomas 11 14 , most variant carriers—estimated at an allele frequency of 1.4% in East Asians on the ExAC database, do not harbour an increased risk of developing cancers over the general population. This negates any clinically significant gene dosage or dominant-negative effect exerted by this variant, and suggests that additional “hits” must occur to confer additional risk.…”
Section: Discussionmentioning
confidence: 99%
“…In keeping with this, we observed that MUTYH c.934-2A > G variant alleles in heterozygous carriers (L130, L279, L522, and L239) were selectively expressed over wild-type alleles, suggesting that most of the MUTYH protein expressed may be defective. Notably, however, although heterozygous c.934-2A > G has been reported in several individuals with colorectal adenomas and carcinomas 11 14 , most variant carriers—estimated at an allele frequency of 1.4% in East Asians on the ExAC database, do not harbour an increased risk of developing cancers over the general population. This negates any clinically significant gene dosage or dominant-negative effect exerted by this variant, and suggests that additional “hits” must occur to confer additional risk.…”
Section: Discussionmentioning
confidence: 99%
“…DNA libraries with an average insert size of 150 bp were sequenced on an Illumina NextSeq 500 or MiSeq platform (Illumina, San Diego, CA, USA). Genetic analysis was performed as previously described . The target gene panel comprised 19 genes related to hereditary CRC, including APC , MUTYH , MLH1 , MSH2 , MSH3 , MSH6 , PMS1 , PMS2 , BUB1 , BUB3 , EPCAM , PTEN , STK11 , SMAD4 , SETD2 , MAX , TSC2 , ATM , and FANCC .…”
Section: Methodsmentioning
confidence: 99%
“…Genetic analysis was performed as previously described. 13 The target gene panel comprised 19 genes related to hereditary CRC, including APC, MUTYH, MLH1, MSH2, MSH3, MSH6, PMS1, PMS2, BUB1, BUB3, EPCAM, PTEN, STK11, SMAD4, SETD2, MAX, TSC2, ATM, and FANCC. All variants found by next-generation sequencing (NGS) were confirmed with Sanger sequencing.…”
Section: Patientsmentioning
confidence: 99%
“…In another study with a larger sample, genetic testing detected a patient with a PMS1 gene biallelic germline pathogenic variant (c.488-489 insA). 51 Yang et al further explored adenomatous polyposis syndrome patients with unknown pathogenic variants. 52 The proband was a female.…”
Section: Mapmentioning
confidence: 99%